(Q37162713)

18 August 2017

1 reference

title

Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

18 August 2017

main subject

0 references

0 references

0 references

Javier P Gisbert

1

1 reference

18 August 2017

Fernando Gomollón

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

The American Journal of Gastroenterology

18 August 2017

published in

1 reference

18 August 2017

volume

103

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

1299-1307

1 reference

Systematic review: managing anaemia in Crohn's disease.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Anemia in IBD: the overlooked villain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Iron, anaemia, and inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Impact of chronic conditions on quality of life in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Economic burden of patients with anemia in selected diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Iron and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Observations on the incidence and cause of anaemia in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Stimulating erythropoiesis in inflammatory bowel disease associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Anemia in patients with chronic inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Anemia in inflammatory bowel disease - the role of recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Sulfasalazine. Adverse effects and desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Are we giving too much iron? Low-dose iron therapy is effective in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Parenteral iron therapy options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

Update on adverse drug events associated with parenteral iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01846.X

10.1111/J.1572-0241.2008.01846.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference